Sumitomo Pharma News

Sumitomo Pharma: Notice regarding corporate split (simple absorption split) of regenerative and cell medicine business and share transfer of subsidiaries

Dec 16 21:30 ET

Sumitomo Pharma: About the absorption split notice published in the Official Gazette

Dec 3 01:30 ET

Sumitomo Pharma: Sumitomo Pharma Announces the Results of Its Early Retirement Program Offer to Employees in Japan for Business Structural Reform

Oct 30 00:30 ET

Sumitomo Pharma: Notice Concerning Finance Costs

Oct 30 00:30 ET

Sumitomo Pharma: Conference on Q2 FY2024 (April 1, 2024 to September 30, 2024) Financial Results

Oct 30 00:30 ET

Sumitomo Pharma: Supplementary Financial Data (IFRS) for the Second Quarter of the Year Ending March 31, 2025

Oct 30 00:30 ET

Sumitomo Pharma: Summary of Consolidated Financial Results for the Second Quarter (First Half) of the Year Ending March 31, 2025 [IFRS]

Oct 30 00:30 ET

Sumitomo Pharma: (Progress of disclosure matters) Notice regarding the results of recruitment of early retirees due to business structural reforms

Oct 30 00:30 ET

Sumitomo Pharma: Notice regarding the recording of financial expenses (exchange losses)

Oct 30 00:30 ET

Sumitomo Pharma: Conference on the financial results for the 1st quarter of the fiscal year 2024 (from April 1, 2024 to June 30, 2024).

Jul 31 02:30 ET

Sumitomo Pharma: Overview of consolidated financial statements for the first quarter of the fiscal year ending March 31, 2025 [IFRS]

Jul 31 02:30 ET

Sumitomo Pharma: Sumitomo Pharmaceuticals has announced that it will provide early retirement programs to its employees in Japan as part of its business restructuring.

Jul 31 02:30 ET

Sumitomo Pharma: Announcements of individual stocks related to the early retirement recruitment due to business structural reform.

Jul 31 02:30 ET

Sumitomo Pharma: Announcements of individual stocks regarding recognition of financial income (exchange gains).

Jul 31 02:30 ET

Sumitomo Pharma: Notice regarding financial income.

Jul 31 02:30 ET

Sumitomo Pharma: Supplementary financial data (IFRS) for the first quarter of the year ending on March 31, 2025.

Jul 31 02:30 ET

Sumitomo Pharma: Corporate Governance Report

Jun 30 21:00 ET

Sumitomo Pharma: Regarding matters related to dominant shareholders.

Jun 25 04:30 ET

Sumitomo Pharma: Legal post-disclosure documents (company split) (FrontAct Corporation)

Jun 17 20:00 ET

Sumitomo Pharma: Legal pre-disclosure documents (company split) (FrontAct Co., Ltd.)

Jun 9 20:00 ET